Search Login Register
Procarbazine
(Matulane)
Summary
Description:
An antineoplastic agent used primarily in combination with mechlorethamine, vincristine, and prednisone (the MOPP protocol) in the treatment of Hodgkin's disease.
Also Known As:
Matulane; Procarbazine Hydrochloride; Cambridge Laboratories Brand of Procarbazine Hydrochloride; Natulan; Procarbazine Monohydrobromide Show All >>
Networked: 971
relevant articles (84 outcomes,
186 trials/studies)
for this Drug
Key Diseases for which Procarbazine is
Relevant
-
Hodgkin Disease (Hodgkin's Disease)
:
35 outcomes 60 studies in 311 results
-
Neoplasms (Cancer)
:
11 outcomes 33 studies in 168 results
-
Glioma (Gliomas)
:
10 outcomes 35 studies in 100 results
-
Lymphoma (Lymphomas)
:
8 outcomes 13 studies in 80 results
-
Glioblastoma (Glioblastoma Multiforme)
:
5 outcomes 16 studies in 44 results
Show All >>
Drugs Related to Procarbazine
-
Vincristine (Oncovin)
-
Prednisone (Sone)
-
Doxorubicin (Adriamycin)
-
Bleomycin (Blenoxane)
-
Mechlorethamine (Nitrogen Mustard)
-
Vinblastine (Vinblastine Sulfate)
-
Cyclophosphamide (Cytoxan)
-
Lomustine (CCNU)
-
Etoposide (VP 16)
-
Dacarbazine (DIC)
Show All >>
Therapies Related to Procarbazine
-
Drug Therapy (Chemotherapy)
-
Radiotherapy
-
Combination Drug Therapy (Combination Chemotherapy)
-
Bone Marrow Transplantation (Transplantation, Bone Marrow)
-
Salvage Therapy
Show All >>
CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.